Favorable results of rituximab in combination with CHOP in the front-line treatment of follicular lymphoma grade 3.

被引：0
|
作者：
Fayad, Luis [1 ]
Overman, Michael [1 ]
Pro, Barbara [1 ]
McLaughlin, Peter [1 ]
Samaniego, Felipe [1 ]
Younes, Anas [1 ]
Romaguera, Jorge Enrique [1 ]
Hagemeister, F. B. [1 ]
Kwak, Larry [1 ]
Rodriguez, Maria Alma [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2770.2770
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2770
引用
收藏
页码：784A / 784A
页数：1
相关论文
共 50 条
  • [1] Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
    Zinzani, PL
    Pulsoni, A
    Perrotti, A
    Soverini, S
    Zaja, F
    De Renzo, A
    Storti, S
    Lauta, VM
    Guardigni, L
    Gentilini, P
    Tucci, A
    Molinari, AL
    Gobbi, M
    Falini, B
    Fattori, PP
    Ciccone, F
    Alinari, L
    Martelli, M
    Pileri, S
    Tura, S
    Baccarani, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2654 - 2661
  • [2] Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile
    Bassi, Simona
    Nassi, Luca
    Pruneri, Giancarlo
    Sammassimo, Simona
    Bertazzoni, Paola
    Gigli, Federica
    Vanazzi, Anna
    Cocorocchio, Emilia
    Mancuso, Patrizia
    Rabascio, Cristina
    Lionetti, Maria Teresa
    Laszlo, Daniele
    Martinelli, Giovanni
    BLOOD, 2009, 114 (22) : 1445 - 1445
  • [3] Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
    Chau, I
    Jones, R
    Cunningham, D
    Wotherspoon, A
    Maisey, N
    Norman, AR
    Jain, P
    Bishop, L
    Horwich, A
    Catovsky, D
    BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 36 - 42
  • [4] Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
    I Chau
    R Jones
    D Cunningham
    A Wotherspoon
    N Maisey
    A R Norman
    P Jain
    L Bishop
    A Horwich
    D Catovsky
    British Journal of Cancer, 2003, 89 : 36 - 42
  • [5] The Follicular Lymphoma International Prognostic Index (FLIPI) predicts treatment outcome in patients with advanced stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP)
    Buske, C
    Hoster, E
    Dreyling, M
    Hasford, J
    Unterhalt, M
    Hiddemann, W
    BLOOD, 2005, 106 (11) : 272A - 272A
  • [6] Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival
    Turturro, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (07) : 959 - 965
  • [7] First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis
    Pouyiourou, M.
    Meyer, A.
    Stroux, A.
    Viardot, A.
    La Rosee, P.
    Maschmeyer, G.
    Kaempfe, D.
    Kahl, C.
    Vucinic, V.
    Monecke, A.
    Hirt, C.
    Weber, T.
    Meissner, J.
    Witzens-Harig, M.
    Boettcher, S.
    Schmalenberg, H.
    Marks, R.
    Prange-Krex, G.
    Kroschinsky, F.
    Hauf, E.
    Keller, U.
    Koch, K.
    Klapper, W.
    Herold, M.
    Scholz, Christian W.
    ANNALS OF HEMATOLOGY, 2020, 99 (12) : 2821 - 2829
  • [8] First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis
    M. Pouyiourou
    A. Meyer
    A. Stroux
    A. Viardot
    P. La Rosée
    G. Maschmeyer
    D. Kämpfe
    C. Kahl
    V. Vucinic
    A. Monecke
    C. Hirt
    T. Weber
    J. Meissner
    M. Witzens-Harig
    S. Böttcher
    H. Schmalenberg
    R. Marks
    G. Prange-Krex
    F. Kroschinsky
    E. Hauf
    U. Keller
    K. Koch
    W. Klapper
    M. Herold
    Christian W. Scholz
    Annals of Hematology, 2020, 99 : 2821 - 2829
  • [9] RITUXIMAB AND CHLORAMBUCIL AS FRONT-LINE TREATMENT FOR FOLLICULAR LYMPHOMA: EXTENDED DISEASE FREE SURVIVAL WITHOUT INCREASED TOXICITY
    Bassi, S.
    Sammassimo, S.
    Gigli, F.
    Negri, M.
    Cocorocchio, E.
    Gardellini, A.
    Rabascio, C.
    Calleri, A.
    Pruneri, G.
    Peccatori, F.
    Laszlo, D.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 109 - 109
  • [10] Follicular Lymphoma Grade 3-To CHOP or not to CHOP?
    Scholz, C. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 14 - 14
12345